Morepen Laboratories Limited (MOREPENLAB) Financial History

Name: Morepen Laboratories Limited (MOREPENLAB) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Morepen Laboratories Limited (MOREPENLAB) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Gurugram, India with about 1,919 employees. Its market capitalization is roughly ₹66 billion. In the fiscal year ended 2026-03-31, MOREPENLAB reported ₹18.0B in revenue and ₹949M in net income.

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

Interactive charts & full statements →

MOREPENLAB Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹18.0B	₹18.0B	₹16.8B	₹14.1B
Gross Profit	₹6.4B	₹6.2B	₹6.0B	₹4.4B
Operating Income (EBIT)	₹892M	₹1.5B	₹1.3B	₹516M
Net Income	₹949M	₹1.2B	₹962M	₹387M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MOREPENLAB Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹5.7B	₹4.8B	₹4.8B	₹4.1B	₹4.3B
Gross Profit	₹2.5B	₹1.9B	₹1.9B	₹1.5B	₹1.6B
Operating Income (EBIT)	₹742M	₹187M	₹359M	₹194M	₹152M
Net Income	₹564M	₹157M	₹275M	₹409M	₹108M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MOREPENLAB Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹109M)	—	—	—	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MOREPENLAB Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹19.4B	₹17.8B	₹12.9B	₹11.1B	—
Total Liabilities	₹6.9B	₹5.9B	₹4.5B	₹3.6B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MOREPENLAB viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

4559 · Zeria Pharmaceutical Co., Ltd. — JPY 89 billion
AARTIPHARM · Aarti Pharmalabs Limited — ₹74 billion
BLISSGVS · Bliss GVS Pharma Limited — ₹73 billion
INNOVACAP · Innova Captab Limited — ₹68 billion
4569 · KYORIN Pharmaceutical Co., Ltd. — JPY 65 billion
SPARC · Sun Pharma Advanced Research Company Limited — ₹63 billion
4886 · ASKA Pharmaceutical Holdings Co.,Ltd. — JPY 62 billion
IOLCP · IOL Chemicals and Pharmaceuticals Limited — ₹60 billion

← MORE-S9 All “M” companies MORN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.